Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Calcium antagonists and sympathetic nerve activation: are there differences between classes?

G Noll1, R R Wenzel, S Shaw

  • 1University Hospital Zürich, Cardiovascular Research, Switzerland.

Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|April 16, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endothelial function and sympathetic nervous system activity in patients with Takotsubo syndrome.

International journal of cardiology·2016
Same author

[New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk : Statement of the D•A•CH Society for Prevention of Cardiovascular Diseases, the Austrian Atherosclerosis Society and the Working Group on Lipids and Atherosclerosis (AGLA) of the Swiss Society for Cardiology].

Der Internist·2014
Same author

The antiproliferative effect of pinostrobin on human umbilical vein endothelial cells (HUVEC).

European review for medical and pharmacological sciences·2013
Same author

Management of hypertension in patients with diabetes mellitus and metabolic syndrome in Swiss primary care.

International journal of clinical practice·2012
Same author

[Effect of paracetamol (acetaminophen) on blood pressure in patients with coronary heart disease].

Praxis·2012
Same author

[Use of diuretics in acute decompensated heart failure].

Praxis·2010

The sympathetic nervous system regulates cardiovascular function, but overactivation can cause hypertension and heart failure. Different calcium antagonists impact sympathetic activity uniquely, with some potentially offering better long-term outcomes.

Area of Science:

  • Cardiovascular Physiology
  • Pharmacology

Background:

  • The sympathetic nervous system is a key regulator of cardiovascular function, influencing heart rate and blood pressure.
  • Overactivation of sympathetic activity is implicated in hypertension and heart failure, impacting patient prognosis.
  • Vasodilators ideally should not activate, and may even blunt, sympathetic activity.

Purpose of the Study:

  • To investigate the differential effects of various calcium antagonists on sympathetic nervous system activity.
  • To compare the impact of short-acting vs. long-acting calcium antagonists on sympathetic responses.
  • To explore potential benefits of specific calcium antagonists in managing hypertension and heart failure through sympathetic modulation.

Main Methods:

  • Review of existing literature on sympathetic nervous system actions and calcium antagonist mechanisms.

Related Experiment Videos

  • Analysis of studies examining heart rate, plasma catecholamines, and noradrenaline levels in response to different calcium antagonists.
  • Comparison of sympathetic nerve activity changes induced by short-acting nifedipine, long-acting nifedipine, verapamil, diltiazem, and second-generation dihydropyridines.

    • Main Results:

    • Short-acting nifedipine significantly increases sympathetic nerve activity and heart rate.
    • Long-acting nifedipine does not increase heart rate but still elevates sympathetic nerve activity.
    • Verapamil and diltiazem lower heart rate, with verapamil potentially suppressing sympathetic activity.

    Conclusions:

    • Different classes of calcium antagonists exhibit distinct effects on sympathetic nervous system activation.
    • Verapamil and diltiazem may offer a more favorable profile by lowering heart rate and not stimulating sympathetic activity.
    • Modulating sympathetic nerve activity with specific calcium antagonists could be beneficial for long-term prognosis in cardiovascular diseases like hypertension and heart failure.